Condition
Atopic
Total Trials
7
Recruiting
1
Active
2
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
29%
2 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 2 (2)
P 3 (1)
P 4 (1)
Trial Status
Completed5
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06547372Not ApplicableRecruiting
Dietary Intervention on Atopy
NCT07011706Phase 2Active Not Recruiting
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
NCT01840605Phase 3Completed
A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis
NCT06436183Phase 2Completed
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
NCT05324618Phase 4CompletedPrimary
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
NCT00806364Completed
Normal Blood, Bone Marrow and Buccal Mucosa Protocol
NCT04182906Not ApplicableCompleted
Pediatric ACEs Screening and Resiliency Study
Showing all 7 trials